0000899243-23-013275.txt : 20230518 0000899243-23-013275.hdr.sgml : 20230518 20230518171857 ACCESSION NUMBER: 0000899243-23-013275 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230516 FILED AS OF DATE: 20230518 DATE AS OF CHANGE: 20230518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOZARICH JOHN W CENTRAL INDEX KEY: 0001223000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 23937169 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-16 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001223000 KOZARICH JOHN W 3911 SORRENTO VALLEY BOULEVARD, SUITE 110 SAN DIEGO CA 92121 1 0 0 0 0 Common Stock 2023-05-16 4 S 0 4444 77.2009 D 38488 D The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $77.20 to $77.24. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number reflected in Column 5 reconciles the total number of shares beneficially held following the transactions reported herein. /s/ Andrew Reardon, Attorney-in-Fact for John W. Kozarich 2023-05-18